HHS Clinical Investigation Oversight Plan Under Development - Henney
This article was originally published in The Tan Sheet
HHS is creating a plan to address certain deficiencies in government oversight of clinical trials, FDA Commissioner Jane Henney, MD, told a meeting of the Association of American Medical Colleges May 11.
You may also be interested in...
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning